R. Dolhoferbliesener et al., IMMUNOLOGICAL DETERMINATION OF ADVANCED GLYCOSYLATION END-PRODUCTS INHUMAN BLOOD AND URINE, Nephrology, dialysis, transplantation, 10(5), 1995, pp. 657-664
Advanced glycosylation end-products (AGE) in human blood and urine wer
e investigated with the aid of an AGE-specific enzyme-linked immunosor
bent assay. Evidence is presented that AGE are natural constituents of
human serum and urine. In diabetics with normal renal function only a
small increase in serum AGE levels was found as compared to normal co
ntrols, while no difference in urinary excretion rate was discernible.
Urinary excretion rate of AGE from diabetic and non-diabetic patients
with end-stage renal disease was reduced, while high serum AGE levels
were observed. AGE in serum occur in a low-molecular-weight fraction
and in a possibly protein-bound high-molecular-weight fraction. In uri
ne from normal controls three immunologically reactive fractions were
detected whose apparent molecular mass ranged from 100 to 1000 Daltons
, while in urine from patients with end-stage renal failure additional
high-molecular-weight fractions appeared.